IR信息FY2021 First Quarter Financial Results Presentation Summary

信息Denka Supplies COVID-19 Rapid Antigen Test Kits to Japanese Government (Updated)

IR信息FY2021 First Quarter Financial Results Presentation Materials

IR信息FY2021 First Quarter Summary of Consolidated Financial Statements

信息Denka Completes Construction of Production Facility to Boost Production of High Functional Transparent Polymers (MS Resin) at Base in Singapore ~Doubling Annual Production Capacity to Approx. 140,000 tons and Enhancing Specialty Business~

信息Denka Receives "Semiconductor of the Year 2021" Award for Development of Denka Spherical Magnesia

信息本日（6月16日）开始销售用于新型冠状病毒变异位点检测的研究试剂 ～可同时检测10种变异位点，为流行病学研究做出贡献～

信息Denka Receives Approval for Marketing of the DELYTACT (G47Δ) Oncolytic Virus in Japan ～Worlds' First Oncolytic Virus against Malignant Glioma～

信息Denka Supplies COVID-19 Rapid Antigen Test Kits to Japanese Government ～The kits will Contribute to Efforts for Preventing the Occurrence of Clusters and Stopping the Spread of Infections.～

IR信息Notice of Convocation of the 162nd Ordinary General Meeting of Shareholders

IR信息Disclosure on the Internet Accompanying the Notice of Convocation of the 162nd Ordinary General Meeting of Shareholders

IR信息FY2020 Financial Results Presentation Materials

信息经营计划"Denka Value-Up" 中间评审

IR信息FY2020 Summary of Consolidated Financial Results

IR信息FY2020 Summary of Consolidated Financial Statements

IR信息Denka Value-Up 中间评审与2022财年数值目标

IR信息Denka Value-Up ～2022财年数值目标与今后2年的措施～

信息关于新型冠状病毒变异株检测系统的开发 ～使用一种试剂同时检测多种变异株，减少检测工作量和实现快速检测～

信息可同时检测新型冠状病毒和流感病毒的试剂盒提交日本药事审批

信息新年致辞